show episodes
 
Artwork

1
Tech Obsessed by Intellias

Hosted by: Regina Viadro, SVP Global Head of Digital Technology Services and President of North America at Intellias, in partnership with Intellas

icon
Unsubscribe
icon
Unsubscribe
Daily+
 
Tech Obsessed is your backstage pass to the minds driving innovation in the most dynamic industries, including media, travel, telecom, healthcare, agriculture, finance and automotive. Created in partnership with Intellias, each episode is a candid conversation between a thought leader from Intellias and a key industry player. Together, they unpack the tech trends reshaping the world and the passions fueling their relentless pursuit of progress. From pioneering breakthroughs to industry-defin ...
  continue reading
 
Artwork

1
Life Science Today

Noah Goodson, PhD

icon
Unsubscribe
icon
Unsubscribe
Monthly
 
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of pe ...
  continue reading
 
Loading …
show series
 
Join the conversation about digital content distribution as Monica shares behind-the-scenes stories from the Olympics in Paris. Discover how voice-based interactions are revolutionizing the consumer experience, and how AR/VR combined with GenAI can personalize immersive storytelling – and more. Guests: Monica Williams - SVP, Digital Products & Oper…
  continue reading
 
This episode discusses AI's role in network optimization, the rise of smart cities, and the evolution of infrastructure with fiber optics and 5G. From smart homes to immersive entertainment, we discuss how these innovations are changing our daily lives. The episode also highlights the importance of inclusivity in STEM, particularly for women in tec…
  continue reading
 
This week, I have an announcement to make. Find out more at https://LifeScienceTodayPodcast.com About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and pri…
  continue reading
 
Vaccine hesitancy, the most expensive gene therapy in the world, a $178M series D, and a $1.3B buyout Find out more at https://LifeScienceTodayPodcast.com Story References Sanofi/Takeda UniQure & CSL Fog Pharma Merck + Imago About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect w…
  continue reading
 
A $145M opioid acquisition, biobucks for the holidays, a series A, and diabetes approvals Find out more at https://LifeScienceTodayPodcast.com Story References Indivior + Opiant Regeneron + CytomX Rezo Provention About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highli…
  continue reading
 
More CRISPR data, oncology wins, and a new player in ophthalmology Find out more at https://LifeScienceTodayPodcast.com Story References Intellia Regeneron Viatris + Oyster Point About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharm…
  continue reading
 
Billion-dollar acquisitions, troubled waters for some biotech’s, and a prosperous outlook for others Find out more at https://LifeScienceTodayPodcast.com Story References Sumitovant + Myovant Thermo Fisher + Binding Site Group Astellas & Taysha Agios Vaxctye About the Show Life Science Today is your source for stories, insights, and trends across t…
  continue reading
 
Some statistically significant guidance, seed to acquisition, some biobucks, and the CART of the future. Find out more at https://LifeScienceTodayPodcast.com Story References FDA AbbVie + DJS Roche + Hookipa Kyverna About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly hig…
  continue reading
 
One biotech is on a roll, another is moving quickly, Amazon money for cancer, and some clinical development news Find out more at https://LifeScienceTodayPodcast.com Story References DICE Odyssey Fred Hutch Merck (MSD), Merck Story 2 About the Show Life Science Today is your source for stories, insights, and trends across the life science industry.…
  continue reading
 
Biotech’s with a series A, a series C, some debt financing, and there is even a Biopharma heading for a SPAC Find out more at https://LifeScienceTodayPodcast.com Story References Nested Therapeutics Cellarity Replimune Estrella Biopharma About the Show Life Science Today is your source for stories, insights, and trends across the life science indus…
  continue reading
 
Major Alzheimer’s news, an ALS approval, and expanded therapies for skin conditions Find out more at https://LifeScienceTodayPodcast.com Story References Eisai + Biogen Amylyx Sanofi + Regeneron About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new tec…
  continue reading
 
A $900 raise, gene therapy news, a quick IPO, and merge three for $100M Find out more at https://LifeScienceTodayPodcast.com Story References Alnylam, Link 2, Link 3 Intellia Therapeutics Third Harmonic Bio Galvanize Therapeutics About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Exp…
  continue reading
 
A critical aesthetics approval, site network buy-up, a very normal oncology biotech, and a busy week for one company. Find out more at https://LifeScienceTodayPodcast.com Story References Revance Velocity + MedPharmics Arsenal SpringWorks Link 1, Link 2, Link 3 About the Show Life Science Today is your source for stories, insights, and trends acros…
  continue reading
 
A $1.1B acquisition, two FDA approvals, and grants for mRNA vaccines. Find out more at https://LifeScienceTodayPodcast.com Story References Novo + Forma Sanofi Boehringer Ingelheim Arcturus About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technolo…
  continue reading
 
Ophthalmology acquisitions, following the pharma trends, and a move in healthcare that is not technology related. Find out more at https://LifeScienceTodayPodcast.com Story References Alcon + Aerie Novartis + Sandoz Labcorp + RWJBH About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. E…
  continue reading
 
Gene therapy approval, opioid costs continue, a $650M deal, and a $3.5B RNA partnership. Find out more at https://LifeScienceTodayPodcast.com Story References Bluebird Endo & Pharmacies Genentech + Jemincare Merck + Orna About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekl…
  continue reading
 
Spending that COVID money, brain money, Irish money, and another oncology approval. Find out more at https://LifeScienceTodayPodcast.com Story References Pfizer Cerevel Abbott AstraZeneca + Daiichi Sankyo About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights abo…
  continue reading
 
This week, we take a break from stories of raising capital, mergers, and FDA approvals to look at the dark side of our industry. What happens when companies fail, people lie, and good drugs make bad lives? Find out more at https://LifeScienceTodayPodcast.com Story References Zymergen + Ginkgo Cassava Teva About the Show Life Science Today is your s…
  continue reading
 
There’s a SPAC, expanded FDA approval, more of the common, and two Bs, two As Find out more at https://LifeScienceTodayPodcast.com Story References ZyVersa Incyte Revolution Frontera CAMP4 ForSight Auron About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights abou…
  continue reading
 
Cell therapy acquisition, royalties sold, biobucks-like deal, successful raise, and Chinese Venture Capital Find out more at https://LifeScienceTodayPodcast.com Story References Vertex + ViaCyte Theravance Biopharma Merck + Orion Pliant Therapeutics Qiming About the Show Life Science Today is your source for stories, insights, and trends across the…
  continue reading
 
FEED DROP - Clinical Research Evolved Noah and John talk with Dan Agroskin, a managing director at a leading private equity firm with a focus on the clinical research industry. We discuss how investments shape industries, what entrepreneurs should think about private equity, and the forces that drive exceptional business growth. Find Out More Dan A…
  continue reading
 
Double acquisition, private money, affordable deals, and a surprising $70M launch Find out more at https://LifeScienceTodayPodcast.com Story References Galapagos + CellPoint + AboundBio Radius Ipsen + Epizyme DEM Bio About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly hi…
  continue reading
 
Crohn’s approval, new VC round, direct offerings, and potential asset sales. Find out more at https://LifeScienceTodayPodcast.com Story References AbbVie Third Rock Scholar Rock Kyowa Kirin About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technolo…
  continue reading
 
Gene therapy, minor legislation, a $625M series D, and four companies raise $373M. Find out more at https://LifeScienceTodayPodcast.com Story References BlueBird FDA Resilience Corvia, Code, Mineralys, Tessa About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights …
  continue reading
 
Pharma buys, pharma splits, pharma trades, and oncology biobucks from pharma Find out more at https://LifeScienceTodayPodcast.com Story References GSK + Affinivax Pfizer – Haleon Regeneron Roche + Repare About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights abou…
  continue reading
 
Pox progress, an oncology acquisition, and we look at $360M worth of biotech funding Find out more at https://LifeScienceTodayPodcast.com Story References Chimerix, Emergent, SIGA Merck & Kelun Inceptor, Laekna, Kriya About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly h…
  continue reading
 
An $11.6B yes, $11.7B delay, drop the A1C with GLP, and a billion bio-bucks Find out more at https://LifeScienceTodayPodcast.com Story References Pfizer + Biohaven Regulators Lilly BridgeBio + BMS About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new t…
  continue reading
 
Resets for biotech, antibiotics approval not enough, continued consolidation, and a normal deal Find out more at https://LifeScienceTodayPodcast.com Story References Zymeworks Phathom Catalyst CenExel Intercept + Advanz About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly…
  continue reading
 
Pharma Q1 reports are rolling in, COVID boost turned sustainable, and weight loss battle looms Find out more at https://LifeScienceTodayPodcast.com Story References Merck Sanofi J&J ThermoFisher Novo Nordisk Eli Lilly About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly h…
  continue reading
 
Drops for reading, a $220M raise, and an acquisition straight out of the movies Find out more at https://LifeScienceTodayPodcast.com Story References Orasis Reify Blackrock + MindX About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pha…
  continue reading
 
The FDA asks for more diversity, $1B for injectors, $2B for a one-trick pony, and $68M to make DNA. Find out more at https://LifeScienceTodayPodcast.com Story References FDA Antares + Halozyme GSK + Sierra Ansa Biotechnologies About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect…
  continue reading
 
Viral therapies, rare disease approvals, and lab space premiums Find out more at https://LifeScienceTodayPodcast.com Story References Pfizer + ReViral Novartis Charles River + Explora Labs About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technolog…
  continue reading
 
Big compensation, mild mergers, a Kite in an updraft, and tightening the biotech belt Find out more at https://LifeScienceTodayPodcast.com Story References Ginkgo Eagle + Acacia Gilead Taysha/Orchard/Silverback About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highligh…
  continue reading
 
$2 billion in capital raises mostly by companies that start with the letter A. Find out more at https://LifeScienceTodayPodcast.com Story References 2seventy Bio Ascendis Apellis Argenx About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies…
  continue reading
 
Case closed on patents, Alzheimer’s data, generic approvals, and expanded approvals. Find out more at https://LifeScienceTodayPodcast.com Story References Alexion + Chugai Biogen Viatris AbbVie About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new tech…
  continue reading
 
Technology for inclusion, layoffs, oncology approvals, and $200M for a tech platform. Find out more at https://LifeScienceTodayPodcast.com Story References Gilead AstraZeneca + Merck + Myriad DNAnexus About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about n…
  continue reading
 
Who owns CRISPR, a collaboration, the classics, and more money for biotech. Find out more at https://LifeScienceTodayPodcast.com Story References Sanofi + Adagene AbbVie + Syndesi Atlas About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies…
  continue reading
 
CRISPR works, the opioid epidemic makes amends (sort of), and the SPAC that wasn’t Find out more at https://LifeScienceTodayPodcast.com Story References Intellia Purdue Pharma Amicus SPAC About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologi…
  continue reading
 
The PD1 that lost, biopharma earns FDA approval, and the Biotech market is cool not dead Find out more at https://LifeScienceTodayPodcast.com Story References Eli Lilly + Innovent Biologics Agios TC Biopharm Blue Water Vaccines Meihua About the Show Life Science Today is your source for stories, insights, and trends across the life science industry…
  continue reading
 
Dragons over unicorns, to CRISPR and beyond, spin-out-and-sell, and expanded approvals. Find out more at https://LifeScienceTodayPodcast.com Story References Arcellx Intellia + Rewrite Navitor + Janssen ViiV About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights …
  continue reading
 
Bispecific antibodies, ocular oncology, Biogen sells, Lilly Builds, and the treatment of a lifetime Find out more at https://LifeScienceTodayPodcast.com Story References Genentech Immunocore Biogen Eli Lilly TenSixteen About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly …
  continue reading
 
Psychedelic SPACs, eczema frenzy, bio-outs without the biobucks, back on track, and the mega-deal that wasn’t Find out more at https://LifeScienceTodayPodcast.com Story References Eleusis Abbvie/Pfizer/Leo UCB + Zogenix Kura GSK - Unilever About the Show Life Science Today is your source for stories, insights, and trends across the life science ind…
  continue reading
 
Oncology partners, Parkinson’s partners, expanded European Commission, expanded FDA, and bacterial vaccines Find out more at https://LifeScienceTodayPodcast.com Story References Scorpion & AstraZeneca ABL & Sanofi Vertex Cochlear Vaxcyte About the Show Life Science Today is your source for stories, insights, and trends across the life science indus…
  continue reading
 
Devices with tech enablement, nano particles, Chinese approvals, and a massive series B for biotechnology Find out more at https://LifeScienceTodayPodcast.com Story References Stryker + Vocera Merck KGaA + Exelead BeiGene Eikon About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expec…
  continue reading
 
We’ve got a new name, gene therapy buyout, a lion of an approval, and an inescapable spotlight. Find out more at https://LifeScienceTodayPodcast.com Story References Novartis + Gyroscope Leo Biogen Biogen 2 About the Show Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights a…
  continue reading
 
Acquiring the acquired, EHR acquisition, first approvals, and a new fund for the new year Originally Published as The Niche Podcast. Find out more at https://LifeScienceTodayPodcast.com Story References CSL + Vifor Oracle + Cerner Calliditas Omega About the Show Life Science Today is your source for stories, insights, and trends across the life sci…
  continue reading
 
Antitrust AI, development AI, expanded approval, mega seeds, and biosimilar SPACs Originally Published as The Niche Podcast. Find out more at https://LifeScienceTodayPodcast.com Story References Microsoft + Nuance Roche + Recursion Heron 1E Alvotech About the Show Life Science Today is your source for stories, insights, and trends across the life s…
  continue reading
 
Double acquisitions in Switzerland, FDA holds and what that means, CMV therapy, rare + oncology continues, BioCryst draws millions, and deer. Originally Published as The Niche Podcast. Find out more at https://LifeScienceTodayPodcast.com Story References Vifor + Sanifit + Inositec Kura Differential Syndrome Takeda Aadi BioCryst USDA About the Show …
  continue reading
 
Top dollar lab notes, lab consolidation, RNA sells, and two new approval areas Originally Published as The Niche Podcast. Find out more at https://LifeScienceTodayPodcast.com Story References Benchling Labcorp Novo Nordisk BioMarin BioMarin 2 AppliedVR AppliedVR 2 Music by Luke Goodson https://www.soundcloud.com/lukegoodson About the Show Life Scie…
  continue reading
 
A giant breaks in two, acquisitions in women’s health, Medicare cost, rare approvals, more CRISPR, and a legacy Originally Published as The Niche Podcast. Find out more at https://LifeScienceTodayPodcast.com Story References Johnson & Johnson Organon Medicare PharmaEssentia Arbor Biotechnologies Glen de Vries About the Show Life Science Today is yo…
  continue reading
 
Loading …

Quick Reference Guide

Listen to this show while you explore
Play